新冠疫情前后挪威与日本儿科门诊抗生素使用及医疗服务利用模式:中断时间序列分析
疫情初期挪威处方率下降45%(RR=0.55;95%CI 0.45-0.67),日本下降53%(RR=0.47;95%CI 0.41-0.55),至2023年恢复至预期水平。疫情前日本广谱抗生素使用(70%)远高于挪威(10%),疫情后挪威广谱使用增加20%而日本基本不变。
要点
- 疫情初期两国儿科抗生素处方率均大幅下降,至2023年恢复至预期水平。
- 日本广谱抗生素占比(70%)远高于挪威(10%),疫情后挪威广谱使用增加20%。
- 有疑似细菌感染诊断的处方比例疫情初期仅小幅下降5%-10%,随后逐步回升。
核心结论
- 新冠疫情显著改变了挪威和日本的儿科抗生素处方模式,疫情后时代需持续开展抗生素管理以确保儿科抗生素合理使用。
研究设计与样本
- 基于人群的研究,使用挪威关联健康登记数据和日本医保理赔数据,覆盖2018-2023年。
- 分析对象为5.5百万儿童和19.5百万张抗生素处方,按月分析处方率、广谱使用比例及有疑似细菌感染诊断的处方比例。
- 采用中断时间序列分析,以2020年3月为中断点,以疫情前趋势/水平为参照,结果以率比(RR)及其置信区间表示。
主要发现
- 疫情前日本抗生素处方率为120-200/1000儿童/月,挪威为10-20/1000儿童/月。
- 疫情初期挪威处方率下降45%(RR=0.55;95%CI 0.45-0.67),日本下降53%(RR=0.47;95%CI 0.41-0.55),至2023年恢复至预期水平。
- 疫情前日本广谱抗生素使用比例为70%,挪威为10%;疫情后挪威广谱使用增加20%,日本基本不变。
- 有疑似细菌感染诊断的处方比例疫情前为50%-65%,疫情初期小幅下降5%-10%,随后两国均逐步回升。
临床怎么用
- 应关注疫情后儿科抗生素处方的恢复趋势,持续监测广谱抗生素使用情况。
- 挪威疫情后广谱抗生素使用增加20%,提示需加强广谱抗生素管理干预。
- 两国处方模式差异显著,可借鉴低处方率国家的管理经验优化儿科抗生素使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Quantification of prescription of antimicrobial agents and use of paediatric outpatient services before, during and after the COVID-19 pandemic. METHODS: We conducted a population-based study using Norwegian linked health registries and Japanese claims (2018-2023). Paediatric antibiotic prescription rates, broad-spectrum use, and proportion of antibiotic prescriptions with prior presumed bacterial infection diagnoses were analysed monthly, overall and by age groups and sex. Interrupted time series analyses were performed to evaluate pandemic-related changes, expressed in rate ratio (RR) and its CI, using March 2020 as the interruption point and the pre-pandemic trend/level as reference. RESULTS: Data on 5.5 million children and 19.5 million antibiotic prescriptions were analysed. Before the pandemic, antibiotic prescribing was higher in Japan (120-200/1000 children/month) than in Norway (10-20/1000). At pandemic onset, rates fell by 45% in Norway (RR = 0.55; 95% CI, 0.45-0.67) and by 53% in Japan (RR = 0.47; 95% CI, 0.41-0.55), then by 2023 had returned to expected levels. Broad-spectrum antibiotic use was much higher in Japan (70%) compared with Norway (10%) before the pandemic. However, Norway experienced a sharp 20% increase whereas Japan remained largely unchanged post-pandemic. The proportion of prescriptions with a prior presumed bacterial diagnosis was between 50% and 65% before the pandemic then decreased modestly by 5%-10% at pandemic onset, followed by gradual rebound in both countries. CONCLUSIONS: The COVID-19 pandemic significantly altered paediatric antibiotic prescribing in both countries. Sustained antibiotic stewardship efforts are needed to ensure appropriate paediatric antibiotic use in the post-pandemic era.
引用
- Trinh NTH, Fukasawa T, Yanai T, et al. Paediatric outpatient antibiotic utilization patterns and use of healthcare services before, during and after the COVID-19 pandemic: interrupted time series analysis using data from Norway and Japan. J Antimicrob Chemother. 2026. PMID: 42313421. doi:10.1093/jac/dkag217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。